FDA approves Botox to treat chronic migraines

Article

G. G.¹^★★ Corresponding author

CORRESPONDENCE

G. G.

Sivagnanam G.

Volume 2, Issue 3 · pp. 216–216 · PUBLISHED 2011 · DOI:

ABSTRACT

As published

Showing references and in-text citations exactly as published.

SELECT FORMAT

G., G. (2011). FDA approves Botox to treat chronic migraines. Journal of Pharmacology and Pharmacotherapeutics, 2(3), 216–216.